摘要 |
The present invention provides pyrazole derivatives represented by the general formula: wherein R<SUP>1 </SUP>represents H, an optionally substituted C<SUB>1-6 </SUB>alkyl group etc.; one of Q and T represents a group represented by the general formula: or a group represented by the general formula: while the other represents an optionally substituted C<SUB>1-6 </SUB>alkyl group etc.; R<SUP>2 </SUP>represents H, a halogen atom, OH, an optionally substituted C<SUB>1-6 </SUB>alkyl group etc.; X represents a single bond, O or S; Y represents a single bond, a C<SUB>1-6 </SUB>alkylene group etc.; Z represents CO or SO<SUB>2</SUB>; R<SUP>4 </SUP>and R<SUP>5 </SUP>represent H, an optionally substituted C<SUB>1-6 </SUB>alkyl group etc.; and R<SUP>3</SUP>, R<SUP>6 </SUP>and R<SUP>7 </SUP>represent H, a halogen atom etc., pharmaceutically acceptable salts thereof or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT1 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, and pharmaceutical compositions comprising the same, pharmaceutical uses thereof, and intermediates for production thereof.
|